home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Pier Shareware 6
/
The_Pier_Shareware_Number_6_(The_Pier_Exchange)_(1995).iso
/
026
/
med9410a.zip
/
M94A0024.TXT
< prev
next >
Wrap
Text File
|
1994-10-01
|
3KB
|
42 lines
Document 0024
DOCN M94A0024
TI Hepatitis C virus seroprevalence in clients of sexually transmitted
disease clinics in North Carolina.
DT 9412
AU Fiscus SA; Kelly WF; Battigelli DA; Weber DJ; Schoenbach VJ; Landis SE;
Wilber JC; Van der Horst CM; Department of Laboratory Medicine,
University of North Carolina; at Chapel Hill 27599.
SO Sex Transm Dis. 1994 May-Jun;21(3):155-60. Unique Identifier : AIDSLINE
MED/94353301
AB BACKGROUND AND OBJECTIVES: The major routes of transmission for
hepatitis C virus (HCV) appear to be blood transfusion and injecting
drug use (IDU). There is still some controversy concerning the role of
sexual transmission in HCV infection. GOAL OF THIS STUDY: To use a well
characterized, high-risk population of STD clinic patients to
investigate the role of sexual transmission of HCV and to determine any
association between HCV, HBV, and HIV. STUDY DESIGN: We tested stored
sera obtained anonymously from clients attending three STD clinics in
North Carolina in 1988 for antibodies to HCV and hepatitis B virus
(HBV). An anonymous, self-administered client questionnaire provided
patient history and demographic information. RESULTS: The most important
risk factor for either HCV or HBV seropositivity was IDU. The only risk
factor associated with HCV seropositivity after the removal of IDUs was
age older than 30 years. In contrast, risk factors associated with HBV
seropositivity after the removal of IDUs included male gender, age older
than 30 years, HIV seropositivity, homosexuality/bisexuality, syphilis
seropositivity, and a history of syphilis. CONCLUSION: Our study of STD
clients confirms the important role that IDU plays in infection with
HCV, but suggests that sexual transmission plays only a minor role in
HCV epidemiology.
DE Adolescence Adult Age Factors Ambulatory Care Facilities Female
Hepatitis Antibodies/*BLOOD Hepatitis B Antibodies/*BLOOD Hepatitis
C/COMPLICATIONS/EPIDEMIOLOGY/IMMUNOLOGY/*TRANSMISSION Human HIV
Seroprevalence Male North Carolina/EPIDEMIOLOGY Risk Factors
Sexually Transmitted Diseases/BLOOD/COMPLICATIONS/*IMMUNOLOGY Substance
Abuse, Intravenous/EPIDEMIOLOGY Support, U.S. Gov't, P.H.S. JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).